T Cell Therapy (Myasthenia gravis)

• Descartes-08

Company: Cartesian Therapeutics

Trial: Phase 2b (estimated completion 31/3/26, no UK trial sites)

• YTB323 

Company: Novartis Pharmaceuticals

Trial: Phase 1/2

Recruiting sites: London and Sheffield

• CC-97540

Company: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company (Responsible Party) 

Trial: Breakfree-2, phase 1

Recruiting sites: London (Barts), London (UCL), Manchester Royal Infirmary, Salford Royal Hospital

• Povetacicept 

Company: Vertex

Trial: Coming in the first half of 2026 for myasthenia gravis